Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Neutropenia × Cilastatin, Imipenem Drug Combination × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Classical hematology 1

Conditions

Neutropenia 1 Neoplasms 1 Hematologic Neoplasms 1 Fever 1 Febrile Neutropenia 1

Interventions

pegfilgrastim 3 Filgrastim 2 posaconazole 1 pegylated granulocyte colony-stimulating factor 1 Vascular Access Devices 1 Vancomycin 1 Teicoplanin 1 Meropenem 1 Leucovorin 1 Lenograstim 1 Irinotecan 1 Fluorouracil 1 Ciprofloxacin 1 Cilastatin, Imipenem Drug Combination 1 Ceftazidime 1 Cefepime 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02149329 2019-09-25

SHORT

Amsterdam UMC, location VUmc

Phase 4 Completed

Classical hematologyOther hematologic neoplasm

Fever, Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡